Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Other Comprehensive Loss (Unaudited)

v3.20.2
Condensed Consolidated Statements of Operations and Other Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Net sales $ 3,840 $ 2,766 $ 9,351 $ 6,735
Cost of sales 2,798 1,932 6,615 5,120
Gross profit 1,042 834 2,736 1,615
Operating expenses:        
Sales and marketing 253 302 548 910
Administration 1,299 936 3,327 3,232
Research and development 57 57 181 246
Total operating expenses 1,609 1,295 4,056 4,388
Loss from operations (567) (461) (1,320) (2,773)
Interest income, net 39 33 53 94
Other expenses (41) (41)
Loss from continuing operations (569) (428) (1,308) (2,679)
Discontinued Operations:        
Income from discontinued operations 161 161
Income from discontinued operations 161 161
Net loss (408) (428) (1,147) (2,679)
Other comprehensive loss:        
Unrealized gain (loss) on marketable debt securities (8) (5) (2) 18
Total comprehensive loss $ (416) $ (433) $ (1,149) $ (2,661)
Basic and diluted earnings (loss) per share:        
loss from continuing operations $ (0.05) $ (0.04) $ (0.11) $ (0.23)
Income from discontinued operations 0.01 0.01
Net loss per share $ (0.04) $ (0.04) $ (0.10) $ (0.23)
Weighted average common shares outstanding:        
Basic and diluted 11,604 11,565 11,593 11,561